Novonix (NVX) Short term Debt (2020 - 2025)

Novonix's Short term Debt history spans 6 years, with the latest figure at $62.1 million for Q4 2025.

  • For Q4 2025, Short term Debt rose 96.0% year-over-year to $62.1 million; the TTM value through Dec 2025 reached $62.1 million, up 96.0%, while the annual FY2025 figure was $62.1 million, 96.0% up from the prior year.
  • Short term Debt reached $62.1 million in Q4 2025 per NVX's latest filing, up from $31.7 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $62.1 million in Q4 2025 to a low of $213351.5 in Q2 2021.
  • Average Short term Debt over 5 years is $19.2 million, with a median of $1.1 million recorded in 2022.
  • Peak YoY movement for Short term Debt: increased 12.84% in 2021, then skyrocketed 3555.73% in 2024.
  • A 5-year view of Short term Debt shows it stood at $213351.5 in 2021, then surged by 394.88% to $1.1 million in 2022, then dropped by 17.95% to $866278.0 in 2023, then surged by 3555.73% to $31.7 million in 2024, then surged by 96.0% to $62.1 million in 2025.
  • Per Business Quant, the three most recent readings for NVX's Short term Debt are $62.1 million (Q4 2025), $31.7 million (Q4 2024), and $866278.0 (Q4 2023).